MX264489B - Industrial method for separation and purification of fentanyl by reverse phase preparative chromatography - Google Patents

Industrial method for separation and purification of fentanyl by reverse phase preparative chromatography

Info

Publication number
MX264489B
MX264489B MXPA06004711A MX264489B MX 264489 B MX264489 B MX 264489B MX PA06004711 A MXPA06004711 A MX PA06004711A MX 264489 B MX264489 B MX 264489B
Authority
MX
Mexico
Prior art keywords
fentanyl
purification
reverse phase
preparative chromatography
phase preparative
Prior art date
Application number
Other languages
English (en)
Spanish (es)
Inventor
Enrico Antonini
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of MXPA06004711A publication Critical patent/MXPA06004711A/es
Publication of MX264489B publication Critical patent/MX264489B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32Bonded phase chromatography
    • B01D15/325Reversed phase
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • B01J20/287Non-polar phases; Reversed phases
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
MXPA06004711 2003-10-29 2006-04-27 Industrial method for separation and purification of fentanyl by reverse phase preparative chromatography MX264489B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51527403P 2003-10-29 2003-10-29

Publications (2)

Publication Number Publication Date
MXPA06004711A MXPA06004711A (es) 2006-07-20
MX264489B true MX264489B (en) 2009-02-12

Family

ID=34572823

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06004711 MX264489B (en) 2003-10-29 2006-04-27 Industrial method for separation and purification of fentanyl by reverse phase preparative chromatography

Country Status (11)

Country Link
US (1) US7728145B2 (enExample)
EP (1) EP1682505B1 (enExample)
JP (1) JP2007509945A (enExample)
CN (1) CN100509785C (enExample)
AT (1) ATE418544T1 (enExample)
AU (1) AU2004287815B2 (enExample)
CA (1) CA2544195A1 (enExample)
DE (1) DE602004018674D1 (enExample)
ES (1) ES2320136T3 (enExample)
MX (1) MX264489B (enExample)
WO (1) WO2005044798A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7486949B2 (en) * 2004-03-10 2009-02-03 Broadcom Corporation Method for re-establishing telephone calls after unintended termination
WO2006055321A2 (en) * 2004-11-10 2006-05-26 Boehringer Ingelheim Chemicals, Inc. Process of making fentanyl intermediates
WO2010033540A1 (en) * 2008-09-19 2010-03-25 Mallinckrodt Inc. Crystalline forms of fentanyl alkaloid
US9724622B2 (en) * 2013-01-29 2017-08-08 Neuland Health Sciences Private Limited Purification of organic compounds using surrogate stationary phases on reversed phase columns
EP3046643A4 (en) * 2013-09-20 2017-05-03 Davuluri, Ramamohan Rao Purification of organic compounds by surfactant mediated preparative hplc
US20220395767A1 (en) * 2021-06-15 2022-12-15 Perkinelmer Health Sciences, Inc. Enhancing lcms analyte signals

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL135583C (enExample) * 1961-10-10
US4234684A (en) * 1979-12-11 1980-11-18 Eli Lilly And Company Method of preparing mycophenolic acid glucoside
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4317903A (en) * 1981-01-26 1982-03-02 The Upjohn Company Process for the purification of lincomycin
US4336333A (en) * 1981-03-13 1982-06-22 Eli Lilly And Company Process for preparing tunicamycin
US4916142A (en) * 1987-02-02 1990-04-10 Boc, Inc. N-heterocyclic-N-(4-piperidinyl)amides and pharmaceutical compositions and their use as analgesics
US4904590A (en) * 1988-12-27 1990-02-27 Eli Lilly And Company Antibiotic A80915 and process for its production
US5780589A (en) * 1994-11-30 1998-07-14 The United States Of America As Represented By The Department Of Health And Human Services Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
EP1053464A1 (en) * 1998-02-03 2000-11-22 Arqule, Inc. Rapid method for separation of small molecules using reverse phase high performance liquid chromatography
EP1246801B1 (en) * 1999-12-06 2006-09-20 Mallinckrodt Inc. Methods for the syntheses of alfentanil, sufentanil and remifentanil
JP2005522460A (ja) * 2002-02-28 2005-07-28 マリンクロッド・インコーポレイテッド 逆相分取用クロマトグラフィーを用いる少なくとも1種の麻薬性アルカロイドの分離および精製のための方法およびシステム
ITRM20020458A1 (it) 2002-09-13 2004-03-14 Ambiotec S A S Di Ammendola Sergio Procedimento per la separazione preparativa degli epimeri di steroidi.

Also Published As

Publication number Publication date
US20070123710A1 (en) 2007-05-31
JP2007509945A (ja) 2007-04-19
EP1682505A1 (en) 2006-07-26
AU2004287815A1 (en) 2005-05-19
DE602004018674D1 (de) 2009-02-05
AU2004287815B2 (en) 2009-05-28
CA2544195A1 (en) 2005-05-19
EP1682505B1 (en) 2008-12-24
ES2320136T3 (es) 2009-05-19
ATE418544T1 (de) 2009-01-15
WO2005044798A1 (en) 2005-05-19
US7728145B2 (en) 2010-06-01
CN100509785C (zh) 2009-07-08
CN1874999A (zh) 2006-12-06
MXPA06004711A (es) 2006-07-20

Similar Documents

Publication Publication Date Title
Nicoud et al. Preparative scale enantioseparation of a chiral epoxide: comparison of liquid chromatography and simulated moving bed adsorption technology
DK0658164T3 (da) Fremgangsmåde til chromatografisk oprensning og adskillelse af nukleinsyreblandinger
DK0470247T3 (da) Kromatografisk proces i omvendt fase.
PT970096E (pt) Purificacao cromatografica de sacarose clorada
KR960022971A (ko) 들깨유로부터 α-리놀렌산(ALA)을 분리, 정제하는 방법
MX2007004855A (es) Metodo para separacion y purificacion de hidrocodona por medio de cromatografia preparativa.
IL155901A0 (en) Adsorptive separation process for recovery of para-xylene
WO2005026323A3 (en) Stationary phases and a purification process using the stationary phases
AU3273200A (en) Ion exchange chromatographic separation of glp-1 and related peptides
PT1107988E (pt) Processo para a purificação cromatográfica de insulinas
DE602004018674D1 (de) Grosstechnisches verfahren zur abtrennung und aufreinigung von fentanyl durch präparative umkehrphasenchromatographie
MX2009005012A (es) Una forma pura de rapamicina y procedimiento para la recuperacion y purificacion de la misma.
CA2548297A1 (en) Process for the purification of macrolides
WO2007052303A3 (en) Process for production of chlorinated sucrose based on hydrophobic affinity chromatography.
WO2004004871A8 (en) Method for separation of isotopes
IL137649A0 (en) Adsorption chromatography
SE0402558D0 (sv) A process for the purification of antibodies
Hodges et al. Multi-column preparative reversed-phase sample displacement chromatography of peptides
Deveant et al. Enantiomer Separation of a Novel Ca‐Sensitizing Drug by simulated moving bed (SMB)–chromatography
JP2007509945A5 (enExample)
WO2002030542A3 (en) Purification of substance by reaction affinity chromatography
Hill et al. Frontal chromatographic techniques in preparative chromatography
DE69708090D1 (de) Umkehrphasenchromatographieverfahren
Zhao et al. “Click chemistry” preparation of WCX packings for protein separation
Saner et al. TRACE-ENRICHMENT TECHNIQUES FOR ORGANIC TRACE ANALYSIS

Legal Events

Date Code Title Description
FG Grant or registration